OBJECTIVE: Compare the antipyretic effects of dipyrone and indomethacin. MATERIALS AND METHODS: Fever was induced in rats by i. v. LPS or i. c. v. interleukins (IL), prostaglandins (PG), arachidonic acid (AA), pre-formed pyrogenic factor (PFPF), tumour necrosis factor-alpha (TNF-alpha) or corticotrophin releasing hormone (CRH). Dipyrone and indomethacin were administered i.p., arginine vasopressin V1-receptor antagonist, d(CH2)5 Tyr(Me)AVP, into the ventral septal area. Cyclooxygenase (COX-1/-2) blocking activity was assessed in transfected COS-7 cells. CRH release from isolated hypothalami was determined by ELISA. RESULTS: Indomethacin or dipyrone reduced LPS, IL-1beta, IL-6 or TNF-alpha induced fever and CRH release from rat hypothalamus. Only dipyrone inhibited IL-8, PFPF or PGF2alpha fever. Only indomethacin inhibited fever induced by AA or IL-1beta, plus AA. Neither antipyretic affected fever caused by PGE2 or CRH. d(CH2)5Tyr(Me)AVP only blocked antipyresis induced by indomethacin. Dipyrone at a very high concentration (10 mM) inhibited only COX-1, while indomethacin (0.1 microM) blocked COX-1 and COX-2 in COS-7 cells. CONCLUSION: The antipyretic effect of dipyrone differs from that of indomethacin in that it does not depend on AVP release or inhibition of PG synthesis.
OBJECTIVE: Compare the antipyretic effects of dipyrone and indomethacin. MATERIALS AND METHODS:Fever was induced in rats by i. v. LPS or i. c. v. interleukins (IL), prostaglandins (PG), arachidonic acid (AA), pre-formed pyrogenic factor (PFPF), tumour necrosis factor-alpha (TNF-alpha) or corticotrophin releasing hormone (CRH). Dipyrone and indomethacin were administered i.p., arginine vasopressin V1-receptor antagonist, d(CH2)5 Tyr(Me)AVP, into the ventral septal area. Cyclooxygenase (COX-1/-2) blocking activity was assessed in transfected COS-7 cells. CRH release from isolated hypothalami was determined by ELISA. RESULTS:Indomethacin or dipyrone reduced LPS, IL-1beta, IL-6 or TNF-alpha induced fever and CRH release from rathypothalamus. Only dipyrone inhibited IL-8, PFPF or PGF2alphafever. Only indomethacin inhibited fever induced by AA or IL-1beta, plus AA. Neither antipyretic affected fever caused by PGE2 or CRH. d(CH2)5Tyr(Me)AVP only blocked antipyresis induced by indomethacin. Dipyrone at a very high concentration (10 mM) inhibited only COX-1, while indomethacin (0.1 microM) blocked COX-1 and COX-2 in COS-7 cells. CONCLUSION: The antipyretic effect of dipyrone differs from that of indomethacin in that it does not depend on AVP release or inhibition of PG synthesis.
Authors: Yi Zhang; Xin Wang; Sergei V Baranov; Shan Zhu; Zhihong Huang; Wendy Fellows-Mayle; Jiying Jiang; Arthur L Day; Bruce S Kristal; Robert M Friedlander Journal: Neurosurgery Date: 2011-10 Impact factor: 4.654
Authors: Denis M Soares; Maria José Figueiredo; Juliano Manvailer Martins; Renes Resende Machado; Carlos Sorgi; Lucia Helena Faciolli; José C Alves-Filho; Fernando Q Cunha; Glória E P Souza Journal: Med Microbiol Immunol Date: 2011-06-05 Impact factor: 3.402
Authors: David do C Malvar; Fernando A Aguiar; Artur de L L Vaz; Débora C R Assis; Miriam C C de Melo; Valquíria A P Jabor; Evanguedes Kalapothakis; Sérgio H Ferreira; Giuliano C Clososki; Glória E P de Souza Journal: Br J Pharmacol Date: 2014-08 Impact factor: 8.739
Authors: David do C Malvar; Denis M Soares; Aline S C Fabrício; Alexandre Kanashiro; Renes R Machado; Maria J Figueiredo; Giles A Rae; Glória E P de Souza Journal: Br J Pharmacol Date: 2011-03 Impact factor: 8.739
Authors: Mia Olsson; Jennifer R S Meadows; Katarina Truvé; Gerli Rosengren Pielberg; Francesca Puppo; Evan Mauceli; Javier Quilez; Noriko Tonomura; Giordana Zanna; Maria José Docampo; Anna Bassols; Anne C Avery; Elinor K Karlsson; Anne Thomas; Daniel L Kastner; Erik Bongcam-Rudloff; Matthew T Webster; Armand Sanchez; Ake Hedhammar; Elaine F Remmers; Leif Andersson; Lluis Ferrer; Linda Tintle; Kerstin Lindblad-Toh Journal: PLoS Genet Date: 2011-03-17 Impact factor: 5.917
Authors: Geórgea V Souza; Alex S Simas; Amanda L Bastos-Pereira; Gisele R A Frois; João L C Ribas; Maria H Verdan; Cândida A L Kassuya; Maria E Stefanello; Aleksander R Zampronio Journal: PLoS One Date: 2015-02-26 Impact factor: 3.240
Authors: Karina F Zoccal; Carlos A Sorgi; Juliana I Hori; Francisco W G Paula-Silva; Eliane C Arantes; Carlos H Serezani; Dario S Zamboni; Lúcia H Faccioli Journal: Nat Commun Date: 2016-02-23 Impact factor: 14.919